Hoot Host is “The Wiser Way” to Grow Online 
Deveron Completes Transaction to Sell Its Assets 
Fonar Announces Financial Results for The 2nd Quarter of Fiscal 2026 Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
COPENHAGEN, Denmark, Feb. 18, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Advances joint commitment from Novavax, Serum Institute of India and Gavi to ensure equitable access…
Trevi Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
NEW HAVEN, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a…
Cambium Networks Reports Fourth Quarter and Full Year 2020 Financial Results
Record revenues of $82.8 million, increased 13% sequentially, up 29% year-over-year Gross margin of 51.0%,…
Larimar Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference
BALA CYNWYD, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome…
Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company…
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging…
Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
OC-01 (Varenicline) Nasal Spray New Drug Application (NDA) Submitted to the U.S. Food and Drug…
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage…
Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Adverum Appoints Christopher J. DeRespino as Chief Business Officer
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Pipeline and capital for growth
Key 2020 events: Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan Gilead decided…
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using…
CBD Companies Will Lose Market Share to Delta 8 THC Hemp Products in 2021
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina,…
GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a…
Turning Point Therapeutics to Host Fourth Quarter and Full-Year 2020 Conference Call
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…